Stem cells transplantation holds great promise for the treatment of ischemic diseases through functional revascularization. Umbilical cord-derived mesenchymal stem cells (UC-MSCs) are also an ideal candidate for cell-based bioengineering. Herein, we report on the development of a simple and effective protocol to isolate UC-MSCs, and confi rm their endothelial potential both in vitro
STEM CELLS AND DEVELOPMENTVolume 19, Number 10, 2010© Mary Ann Liebert, Inc.DOI: 10.1089/scd.2009.0321
Umbilical Cord-Derived Mesenchymal Stem Cells Isolated
by a Novel Explantation Technique Can Differentiate into Functional Endothelial Cells and Promote Revascularization
1Yan Xu ,1, * Hengxing Meng ,2, * Changhong Li ,1 Mu Hao , Yafei Wang ,1 Zhen Yu ,1 Qian Li ,1,2 Junling Han ,1,2
1,2
Qiongli Zhai ,3 and Lugui Qiu
Stem cells transplantation holds great promise for the treatment of ischemic diseases through functional revascu-larization. Umbilical cord-derived mesenchymal stem cells (UC-MSCs) are also an ideal candidate for cell-based
bioengineering. Herein, we report on the development of a simple and effective protocol to isolate UC-MSCs, and confi rm their endothelial potential both in vitro and in vivo. UC-MSCs were isolated by a novel explanta-tion technique and induced to differentiate into endothelial-like cells. Then UC-MSCs were transplanted into ischemic mouse model and cultured on 3D gel/MMT-CS composite scaffolds. Morphological and prolifera-tion assessments show that suffi cient UC-MSCs can be generated during a relatively short culture period with explantation technique. Increased expression of endothelial-specifi c markers (KDR and vWF), and functional markers (ac-LDL uptake and UEA-1 binding), indicate that functional endothelial progenitor cells are induced after 9 days of in vitro culture. In an ischemic hindlimb mouse model, the ratio of ischemic/nonischemic limb perfusion 4 weeks after MSCs transplantation reached 0.84 ± 0.09. The capillary density of this group was 2.57-fold greater than that of sham-injected mice ( P < 0.05). Immunofl uorescence and immunohistological analy-ses indicate that MSCs may act to salvage the ischemic tissue by incorporating into the local vasculature. In vitro, UC-MSCs were observed to incorporate into 3D gel/MMT-CS composite scaffolds, to secrete extracellular matrix, to remain viable, and to retain their proliferation capacity. In conclusion, UC-MSCs isolated by novel yet simple explantation technique are well suited for application in the development of novel stem cell-based revas-cularization therapies.
Introduction
schemic diseases, such as coronary artery disease and peripheral vascular disease, are becoming an increasingly signifi cant problem in terms of morbidity, mortality, and healthcare cost in most countries. The available treatment options for advanced-stage patients are generally limited to angioplasty, balloon dilatation, and other palliative inter-ventions, but many patients with moderate-to-severe isch-emic disease cannot benefi t from such interventions. One possible solution for such patients would involve transplan-tation of a preformed primitive vascular plexus, produced ex vivo by tissue engineering [ 1 ].
I
or a long time, research into ischemia reduction has con-F
centrated on 2 distinct types of vessel growth—angiogene-sis and arteriogenesis. Endothelial cells are key participants in these processes of vessel growth and tissue regenera-tion. Unfortunately, the proliferative capacity of mature endothelial cells is limited, making it necessary to discover alternative cellular sources for autologous and allogeneic use. Human mesenchymal stem cells (MSCs) possess the potential for both powerful ex vivo expansion and versatile differentiation, which places them at the forefront in the fi eld of stem cell-based transplantation and therapy [ 2–4 ]. Although bone marrow (BM) is the most common source of MSCs [ 2 , 5 ], in recent years many groups have turned their
Institute of Hematology & Hospital of Blood Diseases, State Key Laboratory of Experimental Hematology, Chinese Academy of
Medical Sciences & Peking Union of Medical College, Tianjin, People’s Republic of China.
2 Tianjin Cord Blood Bank of National Research Center for Stem Cell Engineering and Technology, Tianjin, People’s Republic of China. 3
Department of Pathology, Tianjin Medical University Cancer Hospital, Tianjin, People’s Republic of China. *These authors contributed equally to this work.
1
1511
umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for...hUCMSCs were isolated from the endothelial/subendothelial layers of the human ...
umbilical cord-derived mesenchymal stem cells during long_生物学_自然科学_...The hUC-MSCs were isolated by culture of tissue adherence, as described ...
LLC 2010 Abstract Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs), isolated from discarded extraembryonic tissue after birth, are promising ...
Human umbilical cord blood-derived mesenchymal stem cells improve ...Administration of cells isolated from human umbilical cord has produced bene?...
Umbilical Cord-Derived M... 暂无评价 12页 5财富值 2008- Derivation of ... Human mesenchymal stem cells isolated from the umbilical cord 隐藏>> Cell ...
Mesenchymal Stem Cells Derived from Dental Tissues_医药卫生_专业资料。英文...umbilical cord blood (UCB) have been isolated and characterized (Mareschi et...
Although umbilical cord blood stem cells and adipose-derived stem cells have...Zuk et al [14] isolated adipose-derived mesenchymal stem cells and found ...
isolated by tissue culture method, which have the... human umbilical cord mesenchymal stem cell; ...cells derived from the Wharton’s jelly portion ...
isolated by tissue culture method, which have the... human umbilical cord mesenchymal stem cell; ...cells derived from the Wharton’s jelly portion ...
RESULTS AND CONCLUSION: After treatment with amphotericin B, umbilical cord-derived mesenchymal stem cells were successfully isolated and cultured in vitro. ...
热门文档